1. Home
  2. BIAF vs DATS Comparison

BIAF vs DATS Comparison

Compare BIAF & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • DATS
  • Stock Information
  • Founded
  • BIAF 2014
  • DATS 2014
  • Country
  • BIAF United States
  • DATS United States
  • Employees
  • BIAF N/A
  • DATS N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • DATS Computer Software: Prepackaged Software
  • Sector
  • BIAF Health Care
  • DATS Technology
  • Exchange
  • BIAF Nasdaq
  • DATS Nasdaq
  • Market Cap
  • BIAF 12.2M
  • DATS 10.4M
  • IPO Year
  • BIAF 2022
  • DATS 2021
  • Fundamental
  • Price
  • BIAF $0.21
  • DATS $2.54
  • Analyst Decision
  • BIAF Hold
  • DATS
  • Analyst Count
  • BIAF 1
  • DATS 0
  • Target Price
  • BIAF N/A
  • DATS N/A
  • AVG Volume (30 Days)
  • BIAF 799.6K
  • DATS 196.9K
  • Earning Date
  • BIAF 05-23-2025
  • DATS 05-27-2025
  • Dividend Yield
  • BIAF N/A
  • DATS N/A
  • EPS Growth
  • BIAF N/A
  • DATS N/A
  • EPS
  • BIAF N/A
  • DATS N/A
  • Revenue
  • BIAF $9,362,022.00
  • DATS $436.00
  • Revenue This Year
  • BIAF N/A
  • DATS N/A
  • Revenue Next Year
  • BIAF $19.99
  • DATS N/A
  • P/E Ratio
  • BIAF N/A
  • DATS N/A
  • Revenue Growth
  • BIAF 269.68
  • DATS N/A
  • 52 Week Low
  • BIAF $0.16
  • DATS $1.01
  • 52 Week High
  • BIAF $2.99
  • DATS $9.34
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 32.86
  • DATS 48.95
  • Support Level
  • BIAF $0.19
  • DATS $2.41
  • Resistance Level
  • BIAF $0.24
  • DATS $2.95
  • Average True Range (ATR)
  • BIAF 0.04
  • DATS 0.22
  • MACD
  • BIAF -0.02
  • DATS 0.02
  • Stochastic Oscillator
  • BIAF 13.80
  • DATS 48.75

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About DATS DatChat Inc.

DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.

Share on Social Networks: